Guía europea de prevención cardiovascular en la práctica clínica. Adaptación española del CEIPC 2008documento resumido. Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC)
- Lobos Bejarano, José María
- Royo Bordonada, Miguel Ángel
- Brotons Cuixart, Carlos
- Alvarez Sala, Luis
- Armario García, Pedro
- Maiques Galán, Antonio
- Mauricio Puente, Didac
- Sans Menéndez, Susana
- Villar Álvarez, Fernando
- Lizcano, Angel
- Gil Núñez, Antonio
- Álvaro Moreno, Fernando de
- Conthe Gutiérrez, Pedro
- Luengo, Emilio
- Río Ligorit, Alfonso del
- Rico, O.
- Santiago Nocito, Ana María de
- Fornés Ubeda, Francisco Vicente
- Martínez, Mercedes
- Lizarbe Alonso, Vicenta
ISSN: 1699-5031
Ano de publicación: 2010
Volume: 5
Número: 2
Páxinas: 68-77
Tipo: Artigo
Outras publicacións en: Revista de la Sociedad Española de Medicina y Seguridad del Trabajo
Resumo
We are pleased to present the Spanish adaptation from the Spanish Committee for Cardiovascular Disease Prevention (CEIPC) of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (IV Joint Task Force of the European Society of Cardiology and Other Societies). This guide is focused on the prevention of cardiovascular disease (CVD) as a whole, including coronary, cerebrovascular, periphery and others, recommending the SCORE model for risk assessment with a 5% threshold for the definition of high-risk. We empathize the need of primary prevention based on lifestyle changes included stop smoking, suitable nutrition and diary physical exercise, with the focus on the health people. The objective is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. A maintained and multidisciplinary professional intervention is required in order to obtain an increase of physical activity, healthy alimentation and smoking cessation in smokers, to the general population and individuals at risk. The decision to start blood pressure treatment will depend upon the BP values, cardiovascular risk and possible damage to target organs or definite CVD. The treatment goal is to achieve BP < 140/90 mmHg, but among patients with diabetes, chronic kidney disease, or definite CVD lower levels (130/80 mmHg) must be pursued. Serum cholesterol must be < 200 mg/dl and cLDL < 130 mg/dl, although among patients with CVD or diabetes, levels below 100 mg/dl (80 mg/dl if feasible particulary in very highrisk patients) must be pursued. Advice and counselling by a health professional is always required in order to keep blood sugar levels controlled (in diabetic type 2 patients, the objective is HbA1C < 7%). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, drugs being administered wherever applicable, with the objective guided by BMI -body mass index- and waist circumference.